![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Smith & Nephew Plc | LSE:SN. | London | Ordinary Share | GB0009223206 | ORD USD0.20 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-3.00 | -0.27% | 1,122.00 | 1,125.50 | 1,126.50 | 1,132.00 | 1,121.00 | 1,123.00 | 3,601,342 | 16:35:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Ortho,prosth,surg Appl,suply | 5.55B | 263M | 0.3008 | 37.42 | 9.84B |
Date | Subject | Author | Discuss |
---|---|---|---|
15/6/2019 16:56 | smashed thru £17.00 barrier! incredible! is it continuing to go up, slowly and surely or is it peak time and slowly and quietly down? this share historically has its cycles, but, under the new team its poss it will continue up and up! | ![]() abbynat | |
11/6/2019 10:36 | - Medical technology company Smith & Nephew said it had agreed to acquire Switzerland-based provider of optical tracking technology Atracsys Sarl, for an undisclosed sum. Atracsys Sarl's technology was used in computer-assisted surgery and its optical tracking camera would assist Smith & Nephew's digital surgery and robotic ecosystem, the company said. The acquisition was expected to complete during the third quarter of 2019. | ![]() broadwood | |
11/6/2019 08:54 | Smith and nephew acquires Atracsys Sarl. Swiss based optical tracking technology used in computer aided surgery. Nice! | kknight01 | |
04/6/2019 20:50 | oh dear! a price drop! i am being sarcastic here. | ![]() abbynat | |
28/5/2019 13:40 | No idea where support lies for this now! I thought 15.50 but it just keeps on going! | kknight01 | |
24/5/2019 21:29 | there seems to be no stopping this train! | ![]() abbynat | |
16/5/2019 03:20 | Products....... leadership....... acquisitions. Sold entire holding for 1620. Just waiting for a pull back to the 1500's to pile it all back in! | kknight01 | |
15/5/2019 21:08 | hello, hello. is anybody there? there seems no stopping to this share! is it the share buyback or sheer positive company products and performance? | ![]() abbynat | |
02/5/2019 09:50 | Excellent start to the year. | ![]() steeplejack | |
12/3/2019 16:40 | Smith & Nephew announces agreement to acquire Osiris Inc. | kknight01 | |
12/3/2019 14:04 | Nuvasive falling sharply as you'd expect.Acceptable Deal by all accounts. | ![]() steeplejack | |
28/2/2019 20:09 | Seems to be good support at 1400. A buy between 1400 - 1450 seems like good value at the moment. Looking at releasing some other stock to top up my holding here. | kknight01 | |
21/2/2019 15:34 | Added a small amount. Has a look of sub 14, perhaps. | ![]() essentialinvestor | |
15/2/2019 13:18 | Just looking at how the share price is behaving, I'm wondering is news imminent here?.. | ![]() essentialinvestor | |
13/2/2019 13:36 | All speculation on my part.. if a deal is confirmed along the lines outlined in the FT, I would expect SN to briefly dip Below 14. Gearing up the balance sheet also makes SN. Less attractive as a potential acquisition target, so that also has to be factored in. Medium to longer term the share price would then depend on whether measures to reignite growth are successful, or not. The recent modest FY dividend rise may also indicate an acquisition is around the corner. | ![]() essentialinvestor | |
12/2/2019 16:31 | Had a read of the conference call transcript, where the CEO makes it crystal clear they are assessing potential acquisitions. Does not necessarily mean the FT story is accurate, however would not rule it out. | ![]() essentialinvestor | |
12/2/2019 03:41 | Nuvasive shareholder list is such that I reckon S&N would be happy to use paper.They don't have to pander to private clients,approaching 90% is institutionally held.Top 10 Institutional Holdings by Shares HeldName Reporting Date Total Holdings Sorted in descending order. Position Value OutstandingShares OwnedBlackrock Inc. 12/31/18 6.2M $308.7M 12.12%Vanguard Group, Inc. (The) 09/30/18 4.7M $230.9M 9.06%Champlain Investment Partners, LLC 09/30/18 3.2M $156.4M 6.14%Price (T.Rowe) Associates Inc 09/30/18 2.3M $116.1M 4.56%State Street Corporation 09/30/18 2.0M $98.3M 3.86%Goldman Sachs Group, Inc. 09/30/18 1.5M $76.0M 2.98%Bank of America Corporation 09/30/18 1.4M $69.8M 2.74%Eagle Asset Management Inc 09/30/18 1.4M $69.2M 2.71%Dimensional Fund Advisors LP 09/30/18 1.3M $63.2M 2.48%Fisher Asset Management, LLC 12/31/18 1.3M $63.1M 2.47% | ![]() steeplejack | |
11/2/2019 12:34 | Jack, how would that be funded. It could not be all debt surely?. With the 500 USD net debt, it would leave SN. With 4 billion of net debt, very approx. | ![]() essentialinvestor | |
11/2/2019 12:30 | Nuvasive NUVA are a buy with Charles Schwab which is encouraging. | ![]() steeplejack | |
11/2/2019 12:20 | Second small lot at just over 14.32. | ![]() essentialinvestor | |
11/2/2019 12:20 | Smith & Nephew was the biggest faller on the FTSE 100 this morning with shares down more than four per cent on reports it is in talks to buy US spine technology Nuvasive in a $3bn (£2.32bn) deal. Shares fell 4.39 per cent to 1,448p today, having closed on Friday at 1,515p. The Financial Times reported the potential deal on Friday after markets closed, sending Nuvasive’s share price up 25 per cent in after hours trading. | ![]() steeplejack | |
11/2/2019 11:59 | NuVasive has $500 in debt, it's market cap is near $3 Billion | ![]() essentialinvestor | |
11/2/2019 09:14 | Bought a few back at 14.52. If the acquisition reports this morning are accurate, SN. may be available lower down, as the price mentioned looks on the steep side. Just imv only. | ![]() essentialinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions